JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewis, J. E.
Right arrow Articles by Miller, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, J. E.
Right arrow Articles by Miller, J. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 154, Issue 1, 46-55, 1966
Copyright © 1966 by American Society for Pharmacology and Experimental Therapeutics


THE USE OF TRITIATED PHENOXYBENZAMINE FOR INVESTIGATING RECEPTORS

Jon E. Lewis 1 and Jack W. Miller 1

1 Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota

Attempts were made to label the adrenergic alpha receptor with phenoxybenzamine-H3 in experiments based on the concept of receptor protection. Radioactivity measurements were made of chloroform-methanol extracts and the remaining nonlipid residues of both protected and nonprotected preparations of the seminal vesicle of the rat. These results were then compared with those obtained from cumulative dose-response curve studies of other preparations. The results obtained with several protecting agents (norepinephrine, phentolamine, cocaine and MJ-1999) led to the conclusion that the radioactivity associated with the nonlipid residue is probably concerned with alpha receptor interaction. It was further concluded that no significant "receptor reserve" for norepinephrine exists in the seminal vesicle. From the values of experiments employing phentolamine, which afforded nearly 100% protection from blockade, it was estimated that there may be as many as 55,000 alpha receptors per smooth muscle cell, and that only a very small portion (0.004%) of the muscle cell surface would be involved in receptor interactions.

Submitted on November 1, 1965
Accepted on April 25, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics.